CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 5 enrolled / 5 target
Drug / intervention
Biopsyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05209061
NCT05209061N/ACompletedUpdate Overdue (0.1/mo)Completion was 5mo ago

Cellular Composition of the Human Appendix Using Single-cell RNA and Single-cell ATAC-sequencing.

Bispebjerg Hospital·observational·Posted Jan 26, 2022·Updated Jun 12, 2026

In Brief

An observational study evaluating Biopsy for Diabetes and 2 related conditions. Completed, enrolled 5 participants across 1 site.

Signals

Enrollment appears stalled

Detailed Summary

The overall purpose of this study is to describe the cellular composition of the human appendix and its gene expression using scRNAseq and scATACseq methods. This will potentially provide is with a complete and detailed map of the appendix´ immunological properties and its role in neuro-endocrine/metabolic functions. Our results will be held up against current knowledge of the appendix and its role in the human body and thus hopefully expand our understanding of this organ and the consequences of its removal by appendectomy.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesDenmark

Timeline

N/ACompletedFinished
20222023202420252026
First PostedJan 26, 2022
Enrollment StartFeb 1, 2023
Primary CompletionJan 28, 2026
Study CompletionJun 10, 2026
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 4.4 years ago

Arms & Interventions

Colo-rectal cancer patientsother

Patients receiving right colectomy or ileo-ceacal resection for colorectal cancer

Other: Biopsy

Interventions

Biopsyother

Participants included in the study, will have a full thickness biopsy of the middle of the appendix taken, after the resected bowel has been removed during surgery.